logo
AAT Bioquest

Screen Quest™ Live Cell Vasopressin receptor 2 (V2R) cAMP Assay Service Pack

Product key features

  • Real-time monitoring: Enables precise, live-cell measurement of intracellular cAMP changes in response to V2R activation.
  • Convenient: Provides all necessary components for precise measurement of V2R-mediated cAMP changes.
  • High-Throughput: Optimized for use with FLIPR, FDSS, and other fluorescence microplate readers, making it ideal for large-scale screening.
  • Simple workflow: Utilizes wash-free calcium sensitive dyes reducing assay complexity and time.

Product description

Vasopressin receptor 2 (V2R), a key GPCR, regulates water homeostasis and fluid balance by activating adenylyl cyclase and increasing intracellular cAMP upon vasopressin binding. Dysregulation of V2R signaling is linked to conditions such as diabetes insipidus, hypertension, and heart failure. Traditional methods often fail to fully capture the signaling complexity of V2R, which primarily couples to adenylyl cyclase to modulate cAMP levels.

The Screen Quest™ Live Cell Vasopressin Receptor 2 (V2R) cAMP Assay Service Pack is specifically designed for real-time, high-throughput monitoring of intracellular cAMP changes associated with V2R activation using transfected cell lines and Calbryte™ 520 wash-free calcium fluorescence detection methods. Unlike conventional assays that require cell lysis, this assay preserves cellular integrity, enabling both temporal and spatial resolution of specific signaling events associated with V2R. This assay employs cell lines transfected to express V2R along with a promiscuous G-protein Gα16. The co-expression of Gα16 enables V2R, which primarily signals through Gs to activate adenylyl cyclase and increase intracellular cAMP levels, while also coupling to Gq signaling to mobilize intracellular calcium. Activation of V2R by specific ligands, such as vasopressin, can be detected using calcium-sensitive dyes such as Calbryte™ 520 AM, Cal-520™ AM, Fluo-8™ AM, Fluo-4™ AM, or corresponding no-wash calcium kits. The inclusion of V2R and Gα16 co-expression ensures robust calcium signaling.

This service pack provides all necessary components for precise measurement of V2R-mediated cAMP changes using FLIPR, FDSS, or equivalent fluorescence microplate readers. It is an ideal tool for studying V2R signaling pathways and evaluating potential therapeutic compounds targeting this receptor, particularly in the context of renal diseases, fluid balance disorders, and cardiovascular research.

Example protocol

AT A GLANCE

Protocol summary
  1. Prepare cells for transfection

  2. Prepare Transfectamine™ 5000-DNA mixture

  3. Add Transfectamine™ 5000-DNA mixture to the cell culture, incubate overnight

  4. Transfer the transfected cells to a 96-well plate 24-30 hours after transfection, and incubate the culture overnight

  5. Add Calbryte™ 520 NW dye-loading solution

  6. Incubate at room temperature or 37 °C for 30-60 minutes

  7. Monitor the fluorescence intensity at Ex/Em = 490/525 nm

Important Note

Thaw the kit components at room temperature before starting the experiment.

CELL PREPARATION

  1. Seed the cells such that they will be ~60-70% confluent at the time of transfection.

  2. Replace with fresh growth medium before transfection. For example, replace with 2 mL of medium per well for 6-well plates and 6 mL of medium for 10 cm plates.

PREPARATION OF STOCK SOLUTIONS

Calbryte™ 520NW stock solution
  1. Add 20 µL of DMSO (Component F) into the vial of Calbryte™ 520NW (Component C), and mix them well.

    Note: 20 µL of Calbryte™ 520NW stock solution is enough for one plate. Unused Calbryte™ 520NW stock solution can be aliquoted and stored at < -20 °C for more than one month, provided the tubes are tightly sealed. Protect from light and avoid repeated freeze-thaw cycles.

PREPARATION OF WORKING SOLUTION

1X Assay Buffer
  1. Combine 9 mL of HHBS (Component E) with 1 mL of 10X Pluronic® F127 Plus (Component D), and mix thoroughly.
Calbryte™ 520NW Working Solution
  1. Add 20 µL of Calbryte™ 520 NW stock solution to 10 mL of 1X Assay Buffer, and mix well.

    Note: The working solution is stable for at least 2 hours at room temperature.

Transfectamine™ 5000-DNA Mixture
  1. Add 15 µL of ddH2O to the vial of Ga16 DNA (Component A) and V2R DNA (Component G), to get the final concentration of 1 µg/µL for both DNAs.

  2. Mix 3 µg of DNA [for example, 1.5 µg of Ga16 DNA (Component A) and 1.5 µg of V2R DNA (Component G)] with 200 µL of serum-free medium.

  3. Add 9 µL of Transfectamine™ 5000 (Component B) to the mixture from Step 2.

  4. Mix well and incubate at room temperature for 20 minutes.

    Note: The ratio of Transfectamine™ 5000 and DNA need to be optimized for different  cell lines. In general, the ratio for Transfectamine™ 5000 Transfection Reagent (µL) to DNA (µg) should be 3-5 µL : 1 µg.

Table 1. Sample  protocols for a 6-well plate and a 10 cm plate

Component 6 well plate (per well) 10 cm plate
Fresh culture medium 2 mL 6 mL
Plasmid ~3 µg 10~15 µg
Serum-free medium 200 µL 600 µL
Transfectamine™ 5000 Transfection Reagent ~9 µL ~30-45 µL

SAMPLE EXPERIMENTAL PROTOCOL

Transfection protocol
  1. Add Transfectamine™ 5000 -DNA mixture to the culture plate and incubate overnight.

    Note: The recombinant protein can start to be detected as early as 16 hours after transfection. The maximal expression level may be observed 72~96 hours after transfection.

  2. Transfer the transfected cells to a 96-well plate 24-30 hours post transfection and incubate overnight.

    • For adherent cells: Plate cells overnight in the growth medium at 40,000 to 80,000 cells/well/100 µL for a 96-well plate.
    • For non-adherent cells: Centrifuge the cells from the culture medium and then suspend the cell pellet in cell growth medium or HHBS at 125,000 to 250,000 cells/well/100 µL for a 96-well poly-D lysine plate. Centrifuge the plate at 800 rpm for 2 minutes with brake off prior to the experiments.

    Note: Each cell line should be evaluated on the individual basis to determine the optimal cell density for the intracellular calcium mobilization.

Calcium assay
  1. Add 100 µL/well (96-well plate) of Calbryte™ 520NW working solution into the cell plate.

  2. Incubate the dye-loaded plate in a cell incubator for 30 minutes, and then incubate the plate at room temperature for another 15-30 minutes.

    Note: If the assay requires 37 °C, perform the experiment immediately without further room temperature incubation.

    Note: If the cells can function well at room temperature for longer time, incubate the cell plate at room temperature for 1 hour (It is recommended that the incubation time be no longer than 2 hours.)

  3. Prepare the compound plate with HHBS or your desired buffer.

  4. Run the calcium flux assay by monitoring the fluorescence intensity at Ex/Em = 490/525 nm.

References

View all 50 references: Citation Explorer
Arginine vasopressin and angiotensin II coregulate Aquaporin 2 expression in M-1 cells.
Authors: Li, Lei and Ge, Wanyue and Zhang, Wenxin and Xu, Zaiping and Xu, Fan and Wang, Yunlai
Journal: Biochemical and biophysical research communications (2025): 151256
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor.
Authors: Brouillette, Rebecca L and Mona, Christine E and Desgagné, Michael and Hassanzedeh, Malihe and Breault, Émile and Lussier, Frédérique and Belleville, Karine and Longpré, Jean-Michel and Grandbois, Michel and Boudreault, Pierre-Luc and Besserer-Offroy, Élie and Sarret, Philippe
Journal: Pharmacological research (2025): 107597
Structural basis of tolvaptan binding to the vasopressin V2 receptor.
Authors: Liu, Hong-Li and Zhong, Hai-Yang and Zhang, Yi-Xiao and Xue, Hua-Rui and Zhang, Zheng-Shuo and Fu, Ke-Quan and Cao, Xu-Dong and Xiong, Xiao-Chun and Guo, Dong
Journal: Acta pharmacologica Sinica (2024): 2441-2449
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease.
Authors: Xiong, Xiaochun and Wang, Naiyuan and Zhang, Yixiao and Zhao, Wenchao and Pang, Ningning and Fu, Kequan and Zhou, Nan and Zhou, Xueyan and Guo, Dong
Journal: Journal of medicinal chemistry (2024): 5935-5944
Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct.
Authors: Khan, Shaza and Raghuram, Viswanathan and Chen, Lihe and Chou, Chung-Lin and Yang, Chin-Rang and Khundmiri, Syed J and Knepper, Mark A
Journal: American journal of physiology. Renal physiology (2024): F57-F68
Page updated on January 18, 2025

Ordering information

Price
Unit size
Catalog Number38213
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Platform

Fluorescence microplate reader

Excitation490 nm
Emission525 nm
Cutoff515 nm
Recommended plateBlack wall, Clear bottom
Instrument specification(s)Bottom read mode, Programmable liquid handling

Components

Figure 1. Vasopressin responses in CHO cells. CHO cells were transiently transfected with Ga16 and vasopressin receptor 2 (V2R). CHO cells were cultured in a 6-well plate and grown to ~60% confluence. Equal amounts of Ga16 (1.5 µg) and V2R plasmids (1.5 µg) were transfected with 9 µL of Transfectamine™ 5000. Cells were transferred to a 96-well plate at 50,000 cells/100 µL/well ~ 30 hours after transfection. 100 µL of Calbryte™ 520NW dye-loading solution was added ~ 48 hours after transfection and incubated at 37 °C for 45 minutes. Vasopressin (50 µL/well) was added using FlexStation 3 to achieve the final concentration of 100 nM.
Figure 1. Vasopressin responses in CHO cells. CHO cells were transiently transfected with Ga16 and vasopressin receptor 2 (V2R). CHO cells were cultured in a 6-well plate and grown to ~60% confluence. Equal amounts of Ga16 (1.5 µg) and V2R plasmids (1.5 µg) were transfected with 9 µL of Transfectamine™ 5000. Cells were transferred to a 96-well plate at 50,000 cells/100 µL/well ~ 30 hours after transfection. 100 µL of Calbryte™ 520NW dye-loading solution was added ~ 48 hours after transfection and incubated at 37 °C for 45 minutes. Vasopressin (50 µL/well) was added using FlexStation 3 to achieve the final concentration of 100 nM.
Figure 1. Vasopressin responses in CHO cells. CHO cells were transiently transfected with Ga16 and vasopressin receptor 2 (V2R). CHO cells were cultured in a 6-well plate and grown to ~60% confluence. Equal amounts of Ga16 (1.5 µg) and V2R plasmids (1.5 µg) were transfected with 9 µL of Transfectamine™ 5000. Cells were transferred to a 96-well plate at 50,000 cells/100 µL/well ~ 30 hours after transfection. 100 µL of Calbryte™ 520NW dye-loading solution was added ~ 48 hours after transfection and incubated at 37 °C for 45 minutes. Vasopressin (50 µL/well) was added using FlexStation 3 to achieve the final concentration of 100 nM.
Screen Quest™ Live Cell Vasopressin receptor 2 (V2R) cAMP assay principle